|4Dec 17, 4:24 PM ET

Ballance David James 4

4 · PhaseBio Pharmaceuticals Inc · Filed Dec 17, 2018

Insider Transaction Report

Form 4
Period: 2018-12-13
Ballance David James
VP, Research and Sci. Affairs
Transactions
  • Purchase

    Common Stock

    2018-12-13$3.94/sh+1,000$3,9407,600 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION